Titan Medical and Conavi Medical: A Transformational Merger Ahead

Titan Medical's Exciting New Chapter with Conavi Medical

Titan Medical Inc. (TSX: TMD; OTC: TMDIF) is excited to announce its management information circular, marking a significant step in its planned amalgamation with Conavi Medical Inc. This strategic move is more than just a merger; it’s a transformative opportunity for Titan's shareholders.

Understanding the Amalgamation Agreement

The recently announced amalgamation agreement sets the stage for an all-stock transaction between Titan Medical and Conavi Medical. This action represents a reverse takeover of Titan, designed to combine the innovative strengths of both companies under one roof.

What This Means for Shareholders

Paul Cataford, Titan’s Interim CEO, emphasizes the potential of this merger, stating, "The Circular presents a compelling case for our shareholders to back this reverse merger with Conavi. We are confident that this transaction offers our existing shareholders a chance to play a part in a groundbreaking commercial-stage venture. Our financial advisors have verified the fairness of this deal, and we are urging shareholders to vote in favor of this transaction."

Details of the Upcoming Transaction

The transaction promises numerous benefits for Titan and its shareholders:

• Growing investment potential in a maturing market.
• Shareholders will retain a significant stake in the newly formed entity.
• A strong leadership team will guide the merged company, facilitating growth in advanced medical devices.
• The closing conditions include a minimum of $7.5 million equity financing that will provide essential capital to the merged operation.

Anticipated Meeting for Shareholder Approval

Titan will conduct an annual general and special meeting on September 30, 2024. At this virtual event, shareholders will vote on the transaction. Cataford urges shareholders to review the Circular diligently and to cast their votes before the deadline, ensuring they are part of this pivotal moment for Titan Medical.

Engagement with Shareholders

Titan is committed to keeping its shareholders informed throughout this process. To facilitate discussions and answer queries, a Q&A session will be hosted ahead of the meeting. Shareholders are encouraged to send their questions on this transaction to Titan's dedicated email address, ensuring all voices are heard.

Board's Strong Support

Titan's board has rallied behind the agreement, unanimously endorsing the merger. They have received an opinion from Raymond James, affirming that the transaction terms are fair from a financial standpoint. This demonstrates the confidence the board has in the future direction of the company.

About Titan Medical

Titan Medical Inc. is a pioneering medical technology company, primarily focusing on enhancing robotic-assisted surgery. Currently headquartered in Toronto, Ontario, Titan boasts an impressive patent portfolio and is actively seeking avenues to further develop its intellectual property while enhancing shareholder value.

About Conavi Medical

Conavi Medical Inc. specializes in innovative imaging technologies essential for minimally invasive cardiovascular procedures. Their patented Novasight Hybrid™ System is a remarkable achievement in the field, having gained significant regulatory approvals, positioning them strongly within the medical technology landscape.

Frequently Asked Questions

What is the rationale behind the merger with Conavi Medical?

Titan believes this transaction will provide growth opportunities and bring together innovative technologies from both companies to create value for shareholders.

When will the shareholder meeting take place?

The meeting is scheduled for September 30, 2024, at 4:00 p.m. Eastern Time.

How can shareholders participate in the voting process?

Shareholders can vote during the virtual meeting or in advance before the voting deadline on September 26, 2024.

What assistance is available for shareholders with questions regarding the merger?

Shareholders can reach out to Shorecrest Group via telephone or email for any assistance or inquiries they may have.

What is Titan's strategic focus moving forward?

Titan aims to further develop and license its technologies, expand its market presence, and enhance shareholder value through innovative partnerships and financial growth.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.